• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的虚拟配体筛选:近期成功案例

Structure-based virtual ligand screening: recent success stories.

作者信息

Villoutreix Bruno O, Eudes Richard, Miteva Maria A

机构信息

INSERM U973, University Paris 7, 75013 Paris, France.

出版信息

Comb Chem High Throughput Screen. 2009 Dec;12(10):1000-16. doi: 10.2174/138620709789824682.

DOI:10.2174/138620709789824682
PMID:20025565
Abstract

Today, computational methods are commonly used in all areas of health science research. Among these methods, virtual ligand screening has become an established technique for hit discovery and optimization. In this review, we first introduce structure-based virtual ligand screening and briefly comment on compound collections and target preparations. We also provide the readers with a list of resources, from chemoinformatics packages to compound collections, which could be helpful to implement a structure-based virtual screening platform. Then we discuss seventeen recent success stories obtained with various receptor-based in silico methods, performed on experimental structures (X-ray crystallography, 12 cases) or homology models (5 cases) and concerning different target classes, from the design of catalytic site inhibitors to drug-like compounds impeding macromolecular interactions. In light of these results, some suggestions are made about areas that present opportunities for improvements.

摘要

如今,计算方法在健康科学研究的各个领域都得到了广泛应用。在这些方法中,虚拟配体筛选已成为一种成熟的命中发现和优化技术。在本综述中,我们首先介绍基于结构的虚拟配体筛选,并简要评论化合物库和靶点制备。我们还为读者提供了一份资源列表,从化学信息学软件包到化合物库,这些资源可能有助于构建基于结构的虚拟筛选平台。然后,我们讨论了十七个最近通过各种基于受体的计算机方法取得的成功案例,这些案例基于实验结构(X射线晶体学,12例)或同源模型(5例),涉及不同的靶点类别,从催化位点抑制剂的设计到阻碍大分子相互作用的类药物化合物。鉴于这些结果,我们对存在改进机会的领域提出了一些建议。

相似文献

1
Structure-based virtual ligand screening: recent success stories.基于结构的虚拟配体筛选:近期成功案例
Comb Chem High Throughput Screen. 2009 Dec;12(10):1000-16. doi: 10.2174/138620709789824682.
2
Free resources to assist structure-based virtual ligand screening experiments.用于辅助基于结构的虚拟配体筛选实验的免费资源。
Curr Protein Pept Sci. 2007 Aug;8(4):381-411. doi: 10.2174/138920307781369391.
3
Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.药物发现中基于配体的虚拟高通量筛选的分子描述符与方法。
Curr Pharm Des. 2006;12(17):2099-110. doi: 10.2174/138161206777585247.
4
Importance of molecular computer modeling in anticancer drug development.分子计算机建模在抗癌药物研发中的重要性。
J BUON. 2007 Sep;12 Suppl 1:S101-18.
5
Novel approaches for targeting the adenosine A2A receptor.靶向腺苷 A2A 受体的新方法。
Expert Opin Drug Discov. 2015 Jan;10(1):63-80. doi: 10.1517/17460441.2015.971006. Epub 2014 Oct 14.
6
In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeutics.蛋白质-蛋白质相互作用的计算机辅助体外筛选:迈向新一代治疗方法
Curr Pharm Biotechnol. 2008 Apr;9(2):103-22. doi: 10.2174/138920108783955218.
7
In silico fragment-mapping method: a new tool for fragment-based/structure-based drug discovery.基于片段的/基于结构的药物发现的新工具:计算片段映射方法。
J Comput Aided Mol Des. 2018 Nov;32(11):1229-1245. doi: 10.1007/s10822-018-0160-8. Epub 2018 Sep 8.
8
The use of protein-ligand interaction fingerprints in docking.蛋白质-配体相互作用指纹图谱在对接中的应用。
Curr Opin Drug Discov Devel. 2008 May;11(3):356-64.
9
Protein structure prediction in structure-based ligand design and virtual screening.基于结构的配体设计和虚拟筛选中的蛋白质结构预测。
Comb Chem High Throughput Screen. 2009 Dec;12(10):940-60. doi: 10.2174/138620709789824718.
10
Counting on Fragment Based Drug Design Approach for Drug Discovery.基于片段的药物设计方法在药物发现中的应用
Curr Top Med Chem. 2018;18(27):2284-2293. doi: 10.2174/1568026619666181130134250.

引用本文的文献

1
Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design.基于结构的药物设计方法在新冠病毒刺突蛋白抑制剂设计中的应用
Curr Top Med Chem. 2022;22(29):2396-2409. doi: 10.2174/1568026623666221103091658.
2
Drug Discovery for Using Structure-Based Computer-Aided Drug Design Approach.基于结构的计算机辅助药物设计方法在药物发现中的应用。
Int J Mol Sci. 2021 Dec 9;22(24):13259. doi: 10.3390/ijms222413259.
3
Synthon-based ligand discovery in virtual libraries of over 11 billion compounds.基于合成子的配体发现虚拟库超过 110 亿化合物。
Nature. 2022 Jan;601(7893):452-459. doi: 10.1038/s41586-021-04220-9. Epub 2021 Dec 15.
4
From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds.从同源建模到命中化合物识别与药物再利用:基于结构的方法发现新型潜在抗肥胖化合物
Methods Mol Biol. 2021;2266:263-277. doi: 10.1007/978-1-0716-1209-5_15.
5
Strategies in Tuberculosis Drug Discovery.结核病药物发现策略。
Molecules. 2020 Feb 4;25(3):665. doi: 10.3390/molecules25030665.
6
DockNmine, a Web Portal to Assemble and Analyse Virtual and Experimental Interaction Data.DockNmine,一个用于组装和分析虚拟和实验交互数据的网络门户。
Int J Mol Sci. 2019 Oct 12;20(20):5062. doi: 10.3390/ijms20205062.
7
Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges.基于结构的虚拟筛选的经验评分函数:应用、关键方面及挑战
Front Pharmacol. 2018 Sep 24;9:1089. doi: 10.3389/fphar.2018.01089. eCollection 2018.
8
Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction.雄激素受体的内分泌干扰:运用分子动力学和对接提高虚拟筛选和毒性预测的能力。
Int J Mol Sci. 2018 Jun 15;19(6):1784. doi: 10.3390/ijms19061784.
9
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay.通过虚拟筛选和体外生物测定发现新型组蛋白去乙酰化酶3(HDAC3)抑制剂。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):525-535. doi: 10.1080/14756366.2018.1437156.
10
HTS and Structure Based Optimization of Indazole-Derived ULK1 Inhibitors.基于高通量筛选和结构的吲唑衍生的ULK1抑制剂优化
ACS Med Chem Lett. 2017 Nov 22;8(12):1258-1263. doi: 10.1021/acsmedchemlett.7b00344. eCollection 2017 Dec 14.